3 results
Approved WMOCompleted
The primary objective of the study is to confirm the efficacy of aliskiren 75 mg, 150 mg and 300 mg in patients with essential hypertension by testing the hypothesis of superior reduction in mean sitting systolic blood pressure (msSBP) from baseline…
Approved WMORecruiting
To determine the uptake of 99mTc-Fucoidan in a fresh thrombus of patients with acute deep vein thrombosis (DVT).
Approved WMOCompleted
To evaluate the tolerability (adverse effects) of 99mTc-Fucoidan in 10 healthy volunteers (phase I).